New consensus recommendations from the Academy of Managed Care Pharmacy ask the U.S. Food and Drug Administration to allow biopharmaceutical companies to share patient health and economic information with policy makers.
Policy makers have often expressed a need to be proactive in receiving patient information ahead of FDA approvals with appropriate safeguards to prevent information from being leaked.
“Enabling proactive dissemination of this information would allow population health decision makers to support more accurate forecasting and rate setting, which would facilitate affordable access for patients to new therapies upon FDA approval,” Academy CEO Susan Cantralell said. “It would also increase the use of value-based payment models by providing sufficient time implement these models in a timely manner.”
Academy recommends patient information be shared with pharmaceutical companies
Alerts Sign-up